Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Atara Biotherapeutics, Inc. (ATRA)  
$0.39 0.00 (0.00%) as of 4:30 Tue 6/18


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 108,674,000
Market Cap: 42.88(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.2298 - $2.31
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  707
Guru Rank Value     : 1.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Atara Biotherapeutics is engaged in T-cell immunotherapy, using its allogeneic Epstein-Barr virus (EBV) T-cell platform to develop therapies for patients with diseases, including tumors, hematologic cancers and autoimmune disease. Co.'s platform utilizes the biology of EBV T cells and has the capability to treat a range of EBV-driven diseases or other diseases through incorporation of engineered chimeric antigen receptors or T-cell receptors. Co.'s T-cell immunotherapy program, tab-cel® (tabelecleucel), is partnered with Pierre Fabre Medicament and is in Phase 3 development for patients with EBV-driven post-transplant lymphoproliferative disease.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 816,825 816,825
Total Buy Value $0 $0 $194,885 $194,885
Total People Bought 0 0 3 3
Total Buy Transactions 0 0 4 4
Total Shares Sold 211,204 267,396 419,842 591,605
Total Sell Value $130,313 $170,773 $340,560 $980,941
Total People Sold 5 5 6 9
Total Sell Transactions 5 10 23 41
End Date 2024-03-28 2023-12-26 2023-06-27 2022-06-27

   
Records found: 736
  Page 24 of 30  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2016-07-20 4 AS $21.99 $105,552 I/I (4,800) 320,311     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2016-07-13 4 GD $0.00 $0 I/I 330,957 0     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2016-07-08 4 AS $22.96 $110,208 I/I (4,800) 325,111     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2016-07-07 4 AS $22.80 $109,440 I/I (4,800) 329,911     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2016-06-24 4 AS $21.32 $102,336 I/I (4,800) 334,711     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2016-06-23 4 AS $21.19 $101,712 I/I (4,800) 339,511     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2016-06-08 4 AS $20.79 $99,792 I/I (4,800) 344,311     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2016-06-07 4 AS $20.25 $146,580 I/I (7,200) 349,111     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2016-05-26 4 AS $17.35 $62,460 I/I (3,600) 356,311     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2016-05-25 4 AS $18.03 $64,908 I/I (3,600) 359,911     -
   Gallagher Carol Giltner Director   –       •      –    2016-05-18 4 AS $15.96 $18,897 D/D (1,184) 95,462     -
   Soffer Gad Chief Operating Officer   •       –      –    2016-05-17 4 AS $15.91 $86,344 D/D (5,427) 136,844     -
   Gallagher Carol Giltner Director   –       •      –    2016-05-16 4 OE $0.00 $0 D/D 2,366 96,646     -
   Mcgrath John Chief Financial Officer   •       –      –    2016-05-16 4 AS $15.77 $85,079 D/D (5,395) 88,822     -
   Mcgrath John Chief Financial Officer   •       –      –    2016-05-16 4 OE $0.00 $0 D/D 10,503 94,217     -
   Haqq Christopher Chief Medical Officer   •       –      –    2016-05-16 4 AS $15.57 $24,990 D/D (1,605) 294,465     -
   Haqq Christopher Chief Medical Officer   •       –      –    2016-05-16 4 OE $0.00 $0 D/D 830 296,070     -
   Soffer Gad Chief Operating Officer   •       –      –    2016-05-16 4 OE $0.00 $0 D/D 13,761 142,271     -
   Fust Matthew K Director   –       •      –    2016-05-16 4 OE $0.00 $0 D/D 1,602 13,888     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2016-05-16 4 OE $0.00 $0 D/D 5,907 223,228     -
   Clark Mitchall G. Chief R & QA Officer   •       –      –    2016-05-16 4 AS $15.15 $62,918 D/D (4,153) 83,759     -
   Clark Mitchall G. Chief R & QA Officer   •       –      –    2016-05-16 4 OE $0.00 $0 D/D 7,212 87,912     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2016-04-26 4 AS $20.15 $2,015 I/I (100) 363,511     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2016-04-25 4 AS $20.12 $24,144 I/I (1,200) 363,611     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2016-04-12 4 AS $20.20 $24,240 I/I (1,200) 364,811     -

  736 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 24 of 30
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed